Whole blood rotation thromboelastometry (ROTEM®) profiles in subjects with non-neoplastic portal vein thrombosis

• Published in: Thrombosis research Vol. 132; no. 2; pp. e131 - e134
• Main Authors: Rossetto, Valeria, Spiezia, Luca, Senzolo, Marco, Rodriguez-Castro, Kryssia I., Maggiolo, Sara, Simioni, Paolo
• Format: Journal Article
• Language: English
• Published: United States Elsevier Ltd 01.08.2013
• Subjects: Adult; Aged; Case-Control Studies; Cirrhosis; Female; Hematology, Oncology and Palliative Medicine; Humans; Male; Middle Aged; Portal Vein; Portal vein thrombosis; Thrombelastography - methods; Thromboelastometry; Venous Thrombosis - blood; Young Adult; CFT; CT; MCF; Cirrhosis; aPTT; PT; ROC; Thromboelastometry; WB; INR; Portal vein thrombosis; PVT; Maximum Clot Firmness; Prothrombin Time; Portal Vein Thrombosis; Clot Formation Time; Whole Blood; International Normalized Ratio; activated Partial Thromboplastin Time; Clotting Time; Receiver Operating Characteristic
• ISSN: 0049-3848; 1879-2472; 1879-2472
• DOI: 10.1016/j.thromres.2013.06.009

The coagulation pattern and the determinants of portal vein thrombosis (PVT), both in patients with and without cirrhosis, are still largely unknown. The aim of this study was to evaluate whole blood thromboelastometry profile, performed by ROTEM®, of both cirrhotic and non-cirrhotic subjects with PVT. Two different groups were considered: i) 14 non-cirrhotic PVT patients, ii) 35 cirrhotic patients with PVT. Controls were sex- and age-matched healthy volunteers and cirrhotic subjects without PVT, respectively. ROTEM® assays (i.e. INTEM, EXTEM, NATEM, and FIBTEM) and traditional coagulative parameters (i.e. platelet count, PT/INR, aPTT, and fibrinogen) were performed on blood samples from each subject. There were no significant differences in ROTEM® profile, as for INTEM, EXTEM, and NATEM assays, and in traditional coagulative parameters, between PVT patients, both with and without cirrhosis, and control groups. Interestingly, Maximum Clot Firmness (MCF) in FIBTEM was significantly higher in non-cirrhotic PVT patients (19mm) than in healthy volunteers (11mm, p<0.05). The amplitude of MCF in FIBTEM revealed to be a useful tool to discriminate non-cirrhotic subjects with PVT from those without thrombotic events. Larger prospective studies are needed to evaluate the relevance of the association between the alterations of ROTEM® profiles and PVT in cirrhotic patients.